Retraction
miR-622 Suppresses Tumor Formation by Directly Targeting VEGFA in Papillary Thyroid Carcinoma
Paper Information
Record ID:
29930
Author(s):
Journal:
Publication Date:
March 16, 2018
Retraction Date:
June 03, 2021
(4.5 years years ago)
Subjects:
Institution:
Department of Nuclear Medicine, China–Japan Union Hospital of Jilin University, Changchun, People’s Republic of ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis - Dove Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reason:
Nature of Retraction:
Retraction
Retraction Notice:
10.2147/OTT.S322704Additional Notes:
see also: https://pubpeer.com/publications/8F1F8512BCE9FC686AE1BEDADD7C9A
Citations (23)
23
Total Citations6
Post-Retraction(26.1%)
17
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
4
Within 1 year
0
After 2+ years
723
Days since retraction (latest)
Comparison of Functional Outcomes of Endoscopic Lobectomy versus Open Lobectomy in Benign Thyroid Disease; A Randomized Controlled Trail
Warda Khalid, Muhammad Imran Khokhar, Syed Jawad Asad Gillani et al. (7 authors)
Unknown Journal
Open Access
Published: May 2023
723 days after retraction
miR-576-5p Promotes the Proliferation of Papillary Thyroid Carcinoma through the MAPK4-AKT Pathway
Rui Hai, Yang Zhou, Fan Li et al. (10 authors)
International Journal of Analytical Chemistry
Open Access
Published: Dec 2022
3 citations
3 citations
574 days after retraction
Circ_KCNQ5 participates in the progression of childhood acute myeloid leukemia by enhancing the expression of RAB10 via binding to miR-622
Xiaoyan Hu, Jiaojiao Yin, Rui He et al. (5 authors)
Hematology
Open Access
Published: Apr 2022
10 citations
10 citations
313 days after retraction
MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment
Maria Papaioannou, Angeliki Chorti, Anthoula Chatzikyriakidou et al. (6 authors)
Frontiers in Oncology
Open Access
Published: Feb 2022
22 citations
22 citations
245 days after retraction
miR-622 Induces Breast Cancer Cell MCF-7 Proliferation, Migration, and Invasion by Directly Negatively Targeting EYA1
Pan Tang, Yanyan Shen, Jihui Yang et al. (7 authors)
Journal of Nanomaterials
Open Access
Published: Jan 2022
5 citations
5 citations
212 days after retraction
Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression
Linwen Zeng, Shaofeng Yuan, Pengfei Zhou et al. (6 authors)
Bioengineered
Open Access
Published: Dec 2021
28 citations
28 citations
199 days after retraction
Identification of novel targets of miR-622 in hepatocellular carcinoma reveals common regulation of cooperating genes and outlines the oncogenic role of zinc finger CCHC-type containing 11
Anne Gaza, Valerie Fritz, Lara Malek et al. (14 authors)
Neoplasia
Open Access
Published: Apr 2021
9 citations
9 citations
40 days before retraction
Epigenetic signature associated with thyroid cancer progression and metastasis
Hong Zhang, Hongliang Duan, Sen Wang et al. (6 authors)
Seminars in Cancer Biology
Published: Mar 2021
15 citations
15 citations
68 days before retraction
Downregulation of miR‐128 Ameliorates Ang II‐Induced Cardiac Remodeling via SIRT1/PIK3R1 Multiple Targets
Heqin Zhan, Feng Huang, Qian Niu et al. (10 authors)
Oxidative Medicine and Cellular Longevity
Open Access
Published: Jan 2021
28 citations
28 citations
153 days before retraction
MicroRNA in Papillary Thyroid Carcinoma: A Systematic Review from 2018 to June 2020
Liviu Hîțu, Katalin Gábora, Eduard-Alexandru Bonci et al. (7 authors)
Cancers
Open Access
Published: Oct 2020
22 citations
22 citations
221 days before retraction
The Changing Face of in vitro Culture Models for Thyroid Cancer Research: A Systematic Literature Review
D Chew, Victoria Green, Andrew Riley et al. (5 authors)
Frontiers in Surgery
Open Access
Published: Jul 2020
10 citations
10 citations
322 days before retraction
miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase
Francesca Maria Orlandella, Raffaela Mariarosaria Mariniello, Peppino Mirabelli et al. (14 authors)
British Journal of Cancer
Open Access
Published: May 2020
30 citations
30 citations
382 days before retraction
<p>MicroRNA-675 directly targets MAPK1 to suppress the oncogenicity of papillary thyroid cancer and is sponged by long non-coding RNA RMRP</p>
Junyi Wang, Tiantian Xiao, Ming Zhao
OncoTargets and Therapy
Open Access
Published: Sep 2019
27 citations
27 citations
641 days before retraction
MicroRNA‐374c‐5p inhibits the development of breast cancer through TATA‐box binding protein associated factor 7‐mediated transcriptional regulation of DEP domain containing 1
Shuai Hao, Wuguo Tian, Yi Chen et al. (7 authors)
Journal of Cellular Biochemistry
Open Access
Published: Jun 2019
23 citations
23 citations
730 days before retraction
miRNA-21 promotes cell proliferation and invasion via VHL/PI3K/AKT in papillary thyroid carcinoma
Chuanshan Zang, Jian Sun, Wenyi Liu et al. (6 authors)
Human Cell
Published: Jun 2019
33 citations
33 citations
731 days before retraction
Constitutive Expression of NRAS with Q61R Driver Mutation Activates Processes of Epithelial–Mesenchymal Transition and Leads to Substantial Transcriptome Change of Nthy-ori 3–1 Thyroid Epithelial Cells
Д. Э. Демин, Marina Afanasyeva, А. Н. Уварова et al. (11 authors)
Biochemistry (Moscow)
Published: Apr 2019
5 citations
5 citations
794 days before retraction
miR-429 suppresses cell growth and induces apoptosis of human thyroid cancer cell by targeting ZEB1
Guochang Wu, Haitao Zheng, Jie Xu et al. (12 authors)
Artificial Cells Nanomedicine and Biotechnology
Open Access
Published: Mar 2019
46 citations
46 citations
818 days before retraction
MicroRNA‑744 suppresses cell proliferation and invasion of papillary thyroid cancer by directly targeting NOB1
Haixia Liu, Jing Guo, Hongyan Chai et al. (4 authors)
Molecular Medicine Reports
Open Access
Published: Jan 2019
5 citations
5 citations
881 days before retraction
The GTP binding activity of transglutaminase 2 promotes bone metastasis of breast cancer cells by downregulating microRNA-205.
Seyoung Seo, Yongwha Moon, Junyoung Choi et al. (12 authors)
PubMed
Published: Jan 2019
25 citations
25 citations
884 days before retraction
Active Surveillance for Papillary Thyroid Microcarcinoma: Challenges and Prospects
Shuai Xue, Peisong Wang, Zachary Hurst et al. (5 authors)
Frontiers in Endocrinology
Open Access
Published: Dec 2018
27 citations
27 citations
903 days before retraction
MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway
Jianjie Zhao, Zhirong Li, Yi Chen et al. (10 authors)
International Journal of Oncology
Open Access
Published: Nov 2018
27 citations
27 citations
945 days before retraction
MicroRNAs as biological regulators in skin disorders
Gautam Singhvi, Prachi Manchanda, Vamshi Krishna Rapalli et al. (6 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Sep 2018
73 citations
73 citations
980 days before retraction
Nanostructured lipid carriers for MicroRNA delivery in tumor gene therapy
Hairong Wang, Shiming Liu, Jia Li et al. (9 authors)
Cancer Cell International
Open Access
Published: Jul 2018
57 citations
57 citations
1056 days before retraction
Quick Stats
Total Citations:
23
Years Since Retraction:
4.5 years
Open Access:
Yes
Last Checked:
Jul 24, 2025